EUVIMEDEUVIMED entdecken
Crossref

Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians

Tingfeng Wu, Junzhao Ye, Suilin Mo, Miaosheng Ye, Xiaoyi Li, Qing Li, Wengeng Wang, Qiaocong Zheng, Ke Luo, Yi Zhang, Shouwei Tu, Daituan Che und 6 weitere

Journal of Gastroenterology and Hepatology · 2024

DOI: 10.1111/jgh.16554 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Gastroenterology and Hepatology, 2024. Verfasst von Tingfeng Wu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Hauptthemen laut MEDLINE: Terminology as Topic, Asian People. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aim The introduction of the latest nomenclature, metabolic associated steatotic liver disease (MASLD), proposed by the multi‐society without Asian society consensus statement, aims to redefine the diagnostic criteria for metabolic associated fatty liver disease (MAFLD). However, its effect on the epidemiology in Asia remains unclear.

Method

We conducted a population‐based cross‐sectional survey on fatty liver disease using multistage stratified random sampling of participants from Guangzhou, a representative area in China (ChiCTR2000033376). Demographic, socioeconomic, lifestyle, and laboratory data were collected. Hepatic steatosis and the severity of fibrosis were assessed using FibroScan.

Results

A total of 7388 individuals were recruited, the proportion of which meeting the definitions for nonalcoholic fatty liver disease (NAFLD), MAFLD, and MASLD were 2359 (31.9%), 2666 (36.1%), and 2240 (30.3%), respectively. One hundred and twenty (1.6%) patients had cryptogenic SLD, and 537 (7.3%) patients were diagnosed with MetALD. MASLD did not significantly differ from NAFLD and MAFLD, except that MAFLD patients had a lower proportion of males, hypertension, and diabetes and were less likely to consume tea ( P < 0.05). Both cryptogenic SLD and MASLD non‐MAFLD patients exhibited milder hepatic steatosis and a lower frequency of liver injury than NAFLD, MAFLD, or MASLD patients (all P < 0.05). An increased HOMA‐IR (adjusted OR: 1.33, 95% CI: 1.10–2.03) was associated with higher risk of moderate‐to‐severe steatosis for MASLD non‐MAFLD patients, while consuming more cups of tea ( P for trend = 0.015) showed inverse associations.

Conclusion

Irrespective of terminology used is that fatty liver disease is highly prevalent in the Han Chinese population. Differences in insulin resistance and lifestyle risk factors are associated with redefinition disparities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Terminology as TopicAsian PeopleHumansMalePrevalenceFemaleCross-Sectional StudiesMiddle AgedAdultProspective StudiesFatty LiverNon-alcoholic Fatty Liver DiseaseChinaMass ScreeningSeverity of Illness IndexAged

Stichwörter der Autor:innen

metabolic associated fatty liver diseasenonalcoholic fatty liver diseaseprevalencesteatotic liver disease

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Gastroenterology, Guangzhou University of Traditional Chinese Medicine Affiliated Foshan Hospital of Traditional Chinese Medicine, Foshan, China.
  • Department of Health Care Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
  • Department of Health Care Center, Guangdong Provincial People's Hospital Affiliated Pingzhou Hospital, Foshan, China.
  • Department of Health Care Center, Yunfu People's Hospital, Yunfu, China.
  • Department of Health Care Center, South China University of Technology Affiliated Nanhai People's Hospital, Foshan, China.

ORCID-Profile: Bihui Zhong

Förderung

  • National Natural Science Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • China Postdoctoral Science Foundation

Zitieren

APA

Wu, T., Ye, J., Mo, S., Ye, M., Li, X., Li, Q., Wang, W., Zheng, Q., Luo, K., Zhang, Y., Tu, S., Che, D., Gong, R., Chen, X., Miu, R., Shao, C., Sun, Y., & Zhong, B. (2024). Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16554

Vancouver

Wu T, Ye J, Mo S, Ye M, Li X, Li Q, et al. Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians. Journal of Gastroenterology and Hepatology. 2024. doi:10.1111/jgh.16554

BibTeX
@article{Wu2024,
  author = {Wu, Tingfeng and Ye, Junzhao and Mo, Suilin and Ye, Miaosheng and Li, Xiaoyi and Li, Qing and Wang, Wengeng and Zheng, Qiaocong and Luo, Ke and Zhang, Yi and Tu, Shouwei and Che, Daituan and Gong, Rulong and Chen, Xing and Miu, Rong and Shao, Congxiang and Sun, Yanhong and Zhong, Bihui},
  title = {Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2024},
  doi = {10.1111/jgh.16554}
}
Kostenlos starten →